Study of Difluprednate in the Treatment of Uveitis

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the safety and efficacy of difluprednate compared with prednisolone acetate in the treatment of endogenous anterior uveitis.

• Phase: Phase 3

Details

• Lead Sponsor: Sirion Therapeutics, Inc.
• Treatments: Difluprednate; Fluprednisolone; Methylprednisolone; Methylprednisolone Acetate; Methylprednisolone Hemisuccinate; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate

Criteria

Inclusion Criteria:

• Diagnosis of endogenous anterior uveitis in at least 1 eye

Exclusion Criteria:

• Presence of intermediate uveitis, posterior uveitis or panuveitis

• Corneal abrasion

• Any confirmed or suspected active viral, bacterial, or fungal keratoconjunctival disease

• Allergy to similar drugs, such as other corticosteroids